NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study on Plasmablastic Lymphoma Patients

RecruitingN/A

Sponsor: Fondazione Italiana Linfomi - ETS

Conditions: Plasmablastic Lymphoma

Countries: Italy

This is an observational, multicenter, international and retrospective study, that aims to collect data on clinical and pathological characteristics, treatment regimens, outcome, and prognostic factors (clinical, biomarkers and/or radio-metabolic) in patients affected by PBL.

Eligibility overview

Sex: ALL

Age: 15 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Diagnosis of plasmablastic lymphoma (PBL) between Jan 1st 2000, and Dec 31st 2022
* Histologically confirmed plasmablastic lymphoma (PBL) diagnosis according to local pathological report
* Age \> 18 years old
* Availability of complete medical records
* Availability of histopathological material requested by the study

Exclusion Criteria:

* Any other histology than PBL
* Lack of complete medical records
* Lack of histopathological material requested by the study

Locations (23)

Aviano, PN, Italy
Ascoli Piceno, Italy
Brescia, Italy
Cuneo, Italy
Florence, Italy
Milan, Italy
Milan, Italy
Milan, Italy
Milan, Italy
Monza, Italy
Novara, Italy
Padova, Italy
Pagani, Italy
Reggio Emilia, Italy
Roma, Italy
Roma, Italy
Roma, Italy
Siena, Italy
Torino, Italy
Torino, Italy
Trento, Italy
Treviso, Italy
Vicenza, Italy